Effects of alpha-lipoic acid supplementation on inflammation, oxidative stress, and serum lipid profile levels in patients with end-stage renal disease on hemodialysis.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/21908204
Conclusion of this study
ALA supplementation significantly reduced hsCRP levels, which is a risk factor for cardiovascular disease in HD patients.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study
